News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Justin Stebbing: Activity of botensilimab/balstilimab in patients with metastatic colon cancer
Jun 16, 2024, 02:00

Justin Stebbing: Activity of botensilimab/balstilimab in patients with metastatic colon cancer

Justin Stebbing shared a post on LinkedIn:

“Really interesting paper out today am part of in Nature Medicine showing activity of botensilimab/balstilimab, a new immunotherapy combination, in heavily pre-treated patients with metastatic colon cancer. Thanks to everyone involved, and all the patients.”

Read further.
Source: Justin Stebbing/LinkedIn 

Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge. He was appointed the first NIHR oncology professor in 2011. He is editor-in-chief of Nature’s cancer journal Oncogene. Prof. Stebbing has published over 700 peer-reviewed papers in leading academic journals. He is a member of the American Society for Clinical Investigation, a fellow of the Royal College of Physicians, and the Royal College of Pathologists, and sits on many advisory boards. He is on the Editorial Board of OncoDaily.

Agustin Pimentel Andrea J. Bullock Ani S. Balmanoukian Anthony B. El-Khoueiry Apostolia M Tsimberidou Benjamin L. Schlechter Breelyn A. Wilky Bruno Bockorny cancer Chloe Delepine Daruka Mahadevan Dhan Chand Gabriel Mednick Gary K. Schwartz Ghassan K. Abou-Alfa Heinz Josef Lenz Jaymin M. Patel Joseph E. Grossman Justin C. Moser Justin Stebbing Katherine Rosenthal Marwan G. Fakih metastatic colon cancer Michael S. Gordon Nature Medicine Neil H. Segal OncoDaily Oncology Rachel E. Sanborn Steven J. O’Day Sunil Sharma Tyler J. Curiel Wei Wu
Special Coverage
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer
Blog
Nov 13, 2024, 08:39
Eva Blondeaux on safety of pregnancy in BRCA carriers
Blog
Nov 13, 2024, 08:39
What can cancer in ferrets, opossums, and even penguins teach us about cancer in humans - AACR
Blog
Nov 13, 2024, 08:36
Research Is The Reason Nicole Seagriff had options to treat her breast cancer - The Breast Cancer Research Foundation
Blog
Nov 13, 2024, 08:30
Patrick Hwu: Exploring the unique partnership between Moffitt Cancer Center and Iovance Biotherapeutics
Insight
Nov 13, 2024, 08:27
Paolo Tarantino: The promise and challenges of response-adapted trials in breast oncology